Improving survival in salivary duct cancer with adjuvant androgen deprivation therapy

Oncotarget. 2019 Jun 11;10(39):3833-3834. doi: 10.18632/oncotarget.27004.

Authors

Wim van Boxtel¹, Carla van Herpen¹

Affiliation

¹ Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.

No abstract available

Keywords: adjuvant therapy; androgen deprivation therapy; antineoplastic agents; hormonal; salivar gland neoplasms.

Publication types

Editorial